Dr. Marwan N. Sabbagh is Chairman of the Scientific Advisory Board at Anavex and lead author of the journal did have access to all the data for sure or do you think they been whispering behind his back when he is in the New York office saying don't tell him that and this?
I have been told from one in the know that the first name in a peer reviewed medical journal is the lead author and basically wrote it, the rest of the persons are just confirming what is written is correct from their part of the trial as you also hinted.
His name and reputation is in that journal, and he is a very prominent person in the Alzheimer's medical community.
If the application with EMA can't hold water compared to what's written in the journal, he will look bad and not trustworthy.
I doubt very much the good doctor would do something like that, why should he?
I remain very confident.
SAVA was a real fruad as explained below, I don't see anything here that remotly rings any alarm bells.
So, to simplify what you said...an old adage...The figures don't lie but liars can figure...Or is it just looking and figuring the data in a different mindset?
Market Data 
Markets 
AI
